…within the scope of the project Structure-based fragment screening targeting Cancer chevron_right Project title: Structure-based fragment screening targeting Cancer PRISMAS Research Area: Healthy People Supervisor: Prof. Pål Stenmark Partner University:…
…beamline at MAX IV offer tools that enable us to understand and subsequently control the stability of clay nanostructures, for instance by targeted additions of salt to quick clay formations,”…
…and its potential as a drug target. Title: SAPUCAIA: The new SAXS beamline at Sirius Speaker: Leandro R.S. Barbosa – Brazilian Synchrotron Light Laboratory Session Chair: Fátima Herranz Associated beamline: CoSAXS…
A unifying theory of superconductivity: Finding common symmetry chevron_right A study in Nature Physics brings science closer to a unified theory of unconventional superconductivity for iron-based materials. Researchers investigated the…
…point. However, current commercial Keap1-targeting drugs covalently inhibit Keap1, a mechanism of action that comes with a lack of selectivity, side effects, and other complications during drug development. “Through this…
…guide for a demo on the three-click procedure. Doing a mesh scan chevron_right The mesh scan can be used for X-ray based crystal centering, as well as fixed-target based SSX…
…impact on the detector the three dimensional momentum vector is obtained. Cooling of the the target atoms before the fragmentation by super sonic expansion or by laser cooling allows a…
…beam, BioMAX is an optimal experimental set-up for X-ray crystallography using microcrystals and ultra-large unit cells. Synchrotron-based serial crystallography (SSX) experiments, using injector or fixed target sample delivery are also…
The Gas-phase end station (GPES), shown in the photo below, has been designed for photoelectron-photoion coincidence (PEPICO) experiments of gas phase targets and samples with high vapour pressure [1]. The main instruments…
…drug candidates to target proteins. Using the beamlines and tools at MAX IV, researchers from drug discovery companies find brand new starting points for developing novel pharmaceutical substances. Easy and…